Ondexxya (Andexanet Alfa)

Andexanet alfa, the active ingredient in Ondexxya, is a reversal agent presented as an intravenous solution for intravenous use. It is employed to rapidly reverse anticoagulant effects in patients treated with specific factor Xa inhibitors. GNH USA supplies Ondexxya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ondexxya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ondexxya is used as a targeted reversal agent for anticoagulation therapy involving factor‑Xa inhibitors. - Life‑threatening or uncontrolled bleeding: Provides rapid restoration of normal clotting in patients on apixaban or rivaroxaban. - Emergency surgery or invasive procedures: Enables safe performance of urgent operations by quickly neutralising anticoagulant activity. - Reversal of anticoagulation during critical care: Restores haemostatic balance in intensive‑care settings where rapid anticoagulant reversal is required.

Common Side Effects: - Infusion‑related reactions:    t  t  t  ...  ...  ...  ... ...   …     …  … … … … … … … … … … ...   g  ... ... inf   g … … … … … … … ... … ... ... … … … … … … … … …

Serious or Rare Side Effects: - Thrombotic events:      ...  …  ... … … ... ... ... ... ... … ... ... ...